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ABSTRACT
Protein termini provide critical insights into the
functional state of individual proteins. With recent
advances in specific proteomics approaches to
enrich for N- and C-terminomes, the global
analysis of whole terminomes at a proteome-wide
scale is now possible. Information on the actual N-
and C-termini of proteins in vivo and any
post-translational modifications, including their
generation by proteolytic processing, is rapidly
accumulating. To access this information we
present version 2.0 of TopFIND (http://clipserve
.clip.ubc.ca/topfind), a knowledgebase for protein
termini, terminus modifications and underlying
proteolytic processing. Built on a protein-centric
framework TopFIND covers five species: Homo
sapiens, Mus musculus, Arabidopsis thaliana,
Saccharomyces cerevisiae and Escherichia coli
and incorporates information from curated commu-
nity submissions, publications, UniProtKB and
MEROPS. Emphasis is placed on the detailed de-
scription and classification of evidence supporting
the reported identification of each cleavage site,
terminus and modification. A suite of filters can be
applied to select supporting evidence. A dynamic
network representation of the relationship be-
tween proteases, their substrates and inhibitors as
well as visualization of protease cleavage site
specificities complements the information dis-
played. Hence, TopFIND supports in depth investi-
gation of protein termini information to spark new
hypotheses on protein function by correlating
cleavage events and termini with protein domains
and mutations.
INTRODUCTION
The function and morphology of a cell is by and large
carried out by its proteome, likewise, that of a tissue by
its cells and their proteomes. The functional state of the
proteome, and hence a cell, is deﬁned by the structures,
interactions and post-translational modiﬁcations of the
proteins present at any given time and place. Proteins
are synthesized as single polypeptide chains that have a
start represented by the amino (N-) terminus, and a
carboxyl (C-) terminus forming its end. Protein termini
are frequently modiﬁed, both cotranslationally and
post-translationally, by a variety of chemical modiﬁca-
tions, including acetylation, methylation, myristoylation
and pyroglutamate formation as well as by proteolytic
processing, which profoundly affect protein stability, lo-
calization and function (1)( Figure 1).
Limited proteolytic processing is a very common and
important post-translational protein modiﬁcation that
plays a major role in almost all essential cellular processes
ranging from cell cycle division and proliferation, to cell
death (2). Exopeptidases trim the polypeptide chain by
one or few amino acids from either the N-terminal or
C-terminal ends and endopeptidases cleave polypeptide
chains internally generating two or more new protein
chains deﬁned by the old and newly formed N- and
C-termini, now referred to as neo-termini (3). Examples
include instances where the N-terminus matches the end of
a signal peptide or pro-peptide indicating maturation and
activation, respectively. Neo-termini found within a
protein or protein domain or between domains are often
associated with loss of the associated functions such as
protein–protein interactions or catalytic activity, in
addition to alterations in protein stability and changes in
cellular location (Figure 1). Therefore, termini not only
deﬁne a protein chain, but are also characteristic of a
protein’s functional competence. Thus, the terminome is
indicative of the competence and functional state of the
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modiﬁcations are a rich information source that are
underexploited for analytical, diagnostic, biomarker or
drug discovery purposes in a wide range of diseases
associated with aberrant proteolysis, such as
Alzheimer’s, colitis, arthritis and cancer.
Recently a number of laboratories have made great
efforts towards high-throughput mass spectrometry-based
identiﬁcation and characterization of protein N-termini
(4–10) and C-termini (11–13). These proteomic methods
now enable experimental determination of protein N-
and C-termini and their modiﬁcations in complex
in vivo samples, as demonstrated by investigations of the
blood plasma N-terminome (14), the mitochondrial
N-terminome (15) and the N-terminome during apoptosis
(7,8,16). More than 50% of the protein termini identiﬁed
in these unbiased N-terminome analyses were products of
limited proteolysis, frequently occurring at unexpected
positions (17), with unknown functional consequences.
Hence, it is key to not only map the protein termini
with existing protein annotation information and so
collect information on their modiﬁcation, but also to cor-
relate this information with the proteolytic processes
generating these chains and termini. In relation to the
last, such events may form biomarkers for disease and
offer new insight into pathological processes.
Many proteases have been characterized in depth by
thorough biochemical analyses in vitro, and novel
methodologies now enable the high-throughput identiﬁca-
tion of protease substrates and their precise cleavage sites
in changing conditions in vivo (18,19). A number of data-
bases like PMAP (20), CutDB (21) and the Degradome
database (22) have been developed to make this detailed
information on proteases and their substrates accessible,
with MEROPS (23) being the gold standard and de facto
authoritative resource. However, these resources are by
design focused on the classiﬁcation of proteases and
their proteolytic activity towards a substrate and do not
provide further knowledge integration and hypothesis
generation. Furthermore, due to their static nature all
these resources are not suited to explore the connections
between different proteases, their inhibitors and substrates
that are collectively known as the protease web (24). An
understanding of the connectivity and the protease web as
a whole is a crucial prerequisite for successful develop-
ment of protease inhibitory drugs.
To address many of these issues we created the
‘Terminus Oriented Protein Function Inferred Database’
(TopFIND) in order to provide a central, user-friendly
knowledgebase that integrates data on protein termini,
their modiﬁcations and information on underlying proteo-
lytic processes extracted from existing valuable re-
sources and make this combined information accessible
to a broad audience. TopFIND has allowed us to
study the proteome-wide distribution and classiﬁcation
of N-termini across species as well as characteristics of
N-terminal amino acid modiﬁcations (17). Here, we
present version 2.0 of TopFIND that has been extended
in content, species coverage and functionality.
TOPFIND FRAMEWORK AND CONTENT
TopFIND is designed as non-redundant, protein centric
database (Figure 2a). Each protein is represented by its
Figure 1. Functional state of a protein inferred from protein termini and cleavage events. A polypeptide chain is initially translated as encoded by
the genome forming a gene encoded N- and C-terminus. Alternate start sites can occur as N-terminal isoforms. Subsequent processing leads to stable
protein chains starting later or stopping earlier in the original polypeptide. Some of these processing events are part of the normal maturation of the
protein during translation, such as methionine removal and signal peptide removal. In contrast, other cleavage events might occur post-translational
and can be protein speciﬁc and necessary during normal protein function or are a result of encounters with a diverse array of proteases. Not shown
here are nuclear targeting sequences or mitochondrial transit sequences that are proteolytically removed upon mitochondrial import. N-terminal
modiﬁcations including acetylation and methylation or C-terminal modiﬁcations such as myristoylation can also occur and profoundly affect protein
localization and function. Hence, identiﬁcation of the termini and modiﬁcations from stable chains can indicate the processing state and functional
potential of the protein. The acetylated N-terminus occurring after removal of the initiator methionine indicates an immature protein as its signal
peptide is still present and suggest instability of this form as acetylation is known as a destabilizing modiﬁcation under certain circumstances.
N-termini located after the signal- or pro-peptide indicate successful targeting and activation respectively with the latter being indicative of an active
protein. The depicted post-translationally created C-terminus removes the transmembrane and protein interaction domains from the protein chain
indicating loss of membrane association and protein–protein interactions and hence a putative change in function.
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detailed by general annotation such as alternative
protein names, protein function and role in disease and
by sequence-speciﬁc annotation as isoforms, domains and
sequence variants. In addition to these commonly
assembled protein characteristics TopFIND catalogs
detailed information on protein chains, termini, modiﬁca-
tions of the terminal amino acid and proteolytic processes.
Additional information on chemical modiﬁcations of
terminal amino acids is integrated from and referenced
against the PSI-MOD ontology (25).
We placed special emphasis on the idea that protein
characteristics, such as its termini, can greatly differ
among tissue types, physiological conditions and experi-
mental systems. To accommodate this we incorporated a
powerful evidence and metadata framework into
TopFIND (Figure 2a) making this information accessible
and usable for comparison of protein characteristics
between speciﬁc conditions.
Each protein chain, terminus, terminus modiﬁcation
and cleavage event listed in TopFIND is accompanied
by detailed records of speciﬁc evidence for its existence
at a given time and location. The evidence information
is structured by the following criteria: (i) Directness: a
qualitative measure [direct, likely direct, likely indirect,
indirect, unknown] describing if the reported cleavage or
terminus (or modiﬁcation etc.) has either been directly
observed (e.g. an N-terminus identiﬁed by Edman
sequencing or proteomics approaches such as ATOMS,
or terminomics approaches such as TAILS or
COFRADIC [for a review, see (19)] or is indirectly
inferred (e.g. by inferring a C-terminus from an experi-
mentally observed neo-N terminus). (ii) Physiological rele-
vance: a qualitative measure of the likelihood that the
identiﬁed terminus, cleavage or inhibition is present and
relevant in vivo [physiologically relevant, likely physiolo-
gically relevant, likely no physiological relevance, no
physiological relevance, unknown]. Examples that can be
considered in this classiﬁcation include whether the sub-
strate was identiﬁed in tissue samples or only in biochem-
ical assays, is native or not, whether the protease is
normally present in a certain cell, tissue or development
stage, or whether it is even present in a given species. (iii)
Conﬁdence value and type: a quantitative measure
describing the conﬁdence that the given observation is
correct. For example, the results generated from prote-
omics data base search programs such as Mascot
includes a peptide identiﬁcation conﬁdence score, which
can be ﬁltered upon by TopFIND. Type refers to the
program or system used to generate these scores. This
differentiation allows for the evaluation and ﬁltering of
conﬁdence values from algorithms and methodologies
that cannot necessarily be directly compared, like for
example a peptide identiﬁcation by mass spectrometry
and sequence determination by Edman sequencing. (iv)
Certainty of protease assignment: a qualitative measure
that the protease assigned to a cleavage is correct. This
reﬂects the possibility of additional proteolytic activities
other than the one studied and reported being present in
the experimental system: [I, no other proteolytic activities
present (e.g. a simple in vitro cleavage assay); II,
Figure 2. Framework and knowledgebase content. (a) TopFIND
employs a protein-centric framework. General and sequence related
annotation is linked to a protein entry identiﬁed by its UniProt acces-
sion. Sequence related annotations such as mutations, cleavage sites or
protein termini are cross correlated based on their relative position. The
focus of TopFIND, that is termini, cleavage events and chains, is
associated with detailed qualitative and quantitative evidence informa-
tion based on controlled vocabularies where deﬁned. (b) Content is
incorporated from curated community contributions, publications,
UniProtKB, MEROPS and PubMED. Upon integration and data re-
trieval the data is processed further by TopFIND and made available
through web and application programming interfaces. (c) Current
TopFIND knowledgebase content by supported species. N- and
C-termini are further split up into their origin.
Nucleic Acids Research, 2012,Vol.40, Database issue D353proteolytic system present but abolished (e.g. denatured);
III, proteolytic system present but impaired (e.g.
inactivated by inhibitors); IV, proteolytic system present
and active (e.g. cell culture or in vivo studies); or
unknown]. (v) Evidence code: categorization [e.g.
inferred from electronic annotation] according to the
controlled evidence vocabulary from the Obo foundry
(26). (vi) Tissue distribution: if relevant, the cells or
tissues in which the observation was made according to
the controlled UniProtKB tissue and cell line vocabulary.
(vii) Method and proteases inhibitors: a dropdown list of
the current main approaches [electronic annotation,
COFRADIC, N-TAILS, C-TAILS, ATOMS, Edman
sequencing, enzymatic biotinylation, chemical
biotinylation, MS (gel based), MS (semi-tryptic peptide
identiﬁcation), MS (other), mutation based analysis]. As
this is an emerging ﬁeld with intense interest, the methods
and approaches for identiﬁcation of protein termini and
protease processing are rapidly developing and change fre-
quently. Hence, the methods used are also captured in free
text. Next the experimental system [cell free, cell culture,
organ or tissue culture, in vivo sample] and the protease
activity and modulation thereof [natural expression, re-
combinant, over expression, knockdown (expression),
genetic knockout, knockdown (functional, protease drug
or blocking antibody or inhibitor used)] are classiﬁed. A
free text ﬁeld is used with prompts to describe the experi-
mental set up. This ensures that also small but important
differences are tracked. As new methods emerge and gain
traction these will be included in updates. Due to the
critical effect of the activity of any other proteases in the
system on the data generated and its interpretation it is
explicitly asked if protease inhibitors were used during
sample preparation and if so which ones. (viii) Source
Database: the database (e.g. MEROPS, neXtProt) from
which the information has been integrated if applicable.
(ix) Laboratory: the research group and corresponding
author who reported the ﬁnding. (x) Publications:
author, title, abstract and full text links for publications
related to the identiﬁcation. (xi) Raw data repository:
links to the raw data supporting the ﬁnding and stored
in external repositories.
Integration of existing resources
Protein entries are retrieved from UniProtKB/Swiss-Prot.
The UniProt accession number is used as a unique iden-
tiﬁer and reference point for all information stored or
generated by TopFIND and for cross references to
external resources (Figure 2b). Extended UniProtKB/
SwissProt protein annotation information including
protein function, sequence, isoform sequences and
sequence variants, domains, modiﬁcations and
cross-references are retained for each entry. Already estab-
lished knowledge on predicted and experimentally veriﬁed
protein N- and C-termini that can be derived from
UniProtKB annotated chain start and end points as well
as from annotations of co-translational methionine
removal is retained in TopFIND. TopFIND evidence
records details of these entries as ‘inferred from electronic
annotation’ of unknown physiological relevance,
directness and conﬁdence with UniProtKB being the
source database.
Information on proteases, their substrates, inhibitors
and cleavage sites is integrated from MEROPS (23) and
mapped on TopFIND protein entities based on the
UniProt accession (Figure 2b). Supplementary data such
as the method details, laboratory of origin and description
listed in MEROPS is retained in the TopFIND evidence
records where possible. In particular the method, labora-
tory and description are retained. The physiological rele-
vance classiﬁcation is retained or stated as ‘unknown’
for ambiguous classiﬁers and the directness and conﬁ-
dence are given as ‘unknown’. The likelihood of
protease assignment classiﬁcation is set as ‘unknown’,
since no comparable evidence codes corresponding to
the MEROPS classiﬁcations ‘theoretical’ and ‘experimen-
tal’ are applied and publication information is attached
where available.
Integration of published studies and user-contributed data
Evidence information for data integrated in bulk from
existing resources is often limited by the lack of supporting
information for the collected knowledge and the use of
different or inconsistent non-controlled vocabulary.
However, the full power of the TopFIND evidence frame-
work can be employed during the integration of individ-
ual or multiple identiﬁcations obtained in a single
carefully controlled and described study. Therefore, we
have manually curated and integrated the results of
several published large-scale terminome studies
(7,9,13–16,27,28). In addition, we have enabled and
strongly encourage data submission from the community
through a user-friendly web interface described in greater
detail below.
Data processing
In addition to direct observations, protein N- and
C-termini can be derived from the vast amount of data
on proteolytic processing. This is automatically inferred
from cleavage information and from the likely extent of
a protein chain and its termini (Figure 2c). Such inferred
protein termini are accompanied with the non-standard
evidence code ‘inferred from cleavage’, a directness of
‘indirect’ and described as ‘unknown’ in the physiological
relevance and conﬁdence entries.
To extract positional and relational information we in-
tegrate the accumulated data further and perform a pos-
itional cross correlation analysis. The position of termini
and cleavage sites is correlated with the positional infor-
mation of protein domains and features like mutations or
active sites. Termini and cleavage sites that match a point
feature or coincide with the start or end of an extended
protein feature are speciﬁcally marked as affected features
and feature boundaries. This is particularly useful if the
function of particular protein domains or sequences are
known, as hypotheses can then be made on the function of
the cleavage fragments versus the intact protein (see
below).
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Following the initial release, in version 2.0 TopFIND has
been expanded and now covers ﬁve major organisms
ranging from prokaryotes to fungi to plants and
mammals, including Escherichia coli, Saccharomyces
cerevisiae, Arabidopsis thaliana, Mus musculus and Homo
sapiens. More are being added over time. The human and
murine TopFIND termini datasets contain signiﬁcant
contributions from experimental N-terminome determin-
ations, whereas protein termini inferred from existing
UniProt/Swissprot annotations dominate the datasets for
the remaining species (Figure 2c). However, this is certain
to change as recently established proteomics based
high-throughput methods become more widely adopted.
The framework provided by TopFIND enables complete
collection and consistent annotation of the emerging data.
INFORMATION RETRIEVAL
We have developed several access routes to the informa-
tion in TopFIND to accommodate a great variety of ques-
tions. A web interface provides a powerful, convenient
and intuitive way to study information on individual
proteins. It is however limited in throughput and difﬁcult
to integrate into existing workﬂows. Therefore, we further
developed two dedicated Application Programming
Interfaces (API). These enable automated querying and
retrieval of TopFIND stored knowledge and facilitate
the integration with other resources and analysis
platforms.
Application programming interfaces
PSICQUIC API. This API is based on the popular PSI
common query interface (PSICQUIC) for standardized
querying of molecular interaction data across multiple
sources (29). Proteolytic cleavage processes, as well as
the inhibition thereof are a speciﬁc form of protein–
protein interaction. Although providing important func-
tional information, protein cleavage events are currently
underrepresented with only 300 out of 16000000 entries
found in 14 molecular interaction resources (http://www
.ebi.ac.uk/Tools/webservices/psicquic/view). To add
TopFIND knowledge to this information pool, all
TopFIND cleavage events and inhibitions are exposed
to PSICQUIC using the reference implementation (29).
The query interface is publicly available at http://
clipserve.clip.ubc.ca/topﬁnd-psicquic-search/query/* and
the SOAP interface can be accessed at http://clipserve.
clip.ubc.ca/topﬁnd-psicquic-ws. An example search query
retrieving the ﬁrst 10 entries is http://clipserve.clip.ubc.ca/
topﬁnd-psicquic-search/query/*:*?ﬁrstResult=0&max
Results=10. This not only allows users to retrieve
TopFIND information using PSIQUIC enabled software
(e.g. in Cytoscape) but also to query information on
protein cleavage events in parallel to general protein–
protein interaction data from all other PSICQUIC
enabled resources (e.g. DrugBank, IntAct, STRING)
using the PSICQUIC View provided by the European
Bioinformatics Institute at http://www.ebi.ac.uk/Tools/
webservices/psicquic/view.
XML API. PSICQUIC is limited to retrieval of the
protein cleavage information. We therefore developed an
additional XML-based API to make the extensive add-
itional information found in TopFIND accessible to auto-
mated retrieval (http://clipserve.clip.ubc.ca/topﬁnd). In
particular, the positional cross correlation analysis is
made accessible to external analysis and annotation
systems. A simple query notation, listed in detail on the
TOPFIND help webpage, allows retrieval of lists with
matching proteins, cleavage events, N- or C-termini. If
the ﬁrst query was not aimed directly at proteins,
detailed information on the corresponding proteins
including all termini, proteolytic processing and substrates
can then be retrieved in a second query using the protein
accession delivered by the ﬁrst query. The returned infor-
mation is XML encoded for automated post-processing
using standard computational procedures.
Web interface
We created a web interface to make the information
compiled by TopFIND available to a broad scientiﬁc
audience. The interface puts protein centric information
at center stage and provides detailed background informa-
tion on amino acid modiﬁcations, a comprehensive docu-
mentation and a step-by-step data contribution system.
Searching. The user is presented with a simple search
interface that allows searching by protein accession
number or name, alternate protein or gene names and,
in the case of proteases, by MEROPS family identiﬁers.
An advanced search interface can be used to restrict the
search by species, genomic location, presence of speciﬁc
terminal amino acid modiﬁcations, number of reported
C- or N-termini, or restricted to proteases or their inhibi-
tors. This allows for complex queries, for example
searching for N-terminally acetylated human proteins
encoded on a speciﬁc chromosome.
The output of a successful search for a protein of
interest is presented with a detailed protein overview
page composed of seven sections. Some of these may
also be exported as a tab-delimited spreadsheet for
ofﬂine use.
Protein annotation and domain structure. General protein
information, the sequence and isoform sequences are
accompanied by MEROPS protease classiﬁcation if ap-
plicable and more detailed protein annotation derived
from UniProtKB. This overview is followed by a graphical
depiction of the sequential arrangement of protein
domains, features, termini and cleavage events. This
allows for easy assessment how termini and cleavage
events relate to each other as well as to protein domains
and features (Figure 3). Evidence information for termini
and cleavage events is directly accessible in the overlay
linked to their graphical representation in the domain
overview.
Protein termini and processing. Proteolytic processing of
the protein, its substrates and known protein termini are
listed in separate sections. Each terminus or cleavage event
(of the protein itself and, in the case of proteases, or one of
Nucleic Acids Research, 2012,Vol.40, Database issue D355its substrates) is listed along with the position, the local
sequence context and supporting evidence. The compre-
hensive evidence information including the methodology,
a description and abstracts from related publications is
accessible through links opening as overlays. In addition
all results of the cross correlation analyses are displayed.
This section makes it easy to identify potential physio-
logical implications as detailed below.
All termini and cleavage site listings can be exported as
tab-delimited spreadsheets to allow further ofﬂine analysis
and visualization.
Protease web. An interactive network graph visualizes the
relation of the queried protein to multiple proteases, their
inhibitors and shared as well as unique substrates
(Figure 4). The dynamic network representation is
realized using Cytoscape Web (30) and allows the user
to browse the protease web. Clicking on a node of
interest opens the corresponding protein page and
re-focuses the protease web around that protein. Use of
the evidence ﬁltering mechanism described below enables
to study complex questions such as differences in connect-
ivity and redundancy in various species, cell lines or
conditions.
Protease cleavage speciﬁcity. The cleavage site sequence
speciﬁcity for proteases is calculated from their associated
substrate cleavage sites and displayed both as a heatmap
(absolute amino acid occurrence percentages) and as an
iceLogo, which corrects for the natural amino acid distri-
bution and tests for statistic signiﬁcance (31)( Figure 5).
Online documentation and help. Throughout the page
small question marks provide access to short explanations
parameters or entry ﬁelds. In addition an extensive online
documentation section provides in depth explanation of
all options and parameters from searching over data in-
terpretation to data submission.
Data submission. We strongly encourage the scientiﬁc
community to batch upload relevant experimental data
on protein termini and protease cleavage sites directly to
TopFIND. A detailed guide including screenshots of every
step and provided as downloadable PDF ﬁle guides the
user through the submission process. The submission
interface is password protected to prevent abuse by auto-
mated systems, but registration is free and requires only a
valid e-mail address and choice of a password. After login,
data can be uploaded as a comma separated ﬁle describing
the reported termini or cleavage events and following a
concise format described in detail on the submission site.
A complementing electronic form asks for detailed de-
scriptions of the experimental system and employed meth-
odology automatically linking the provided information
Figure 3. A substrate example. Chemokine function is altered by proteolytic processing. (a) Domain structure, cleavage sites and termini of human
C-X-C motif chemokine 11 (CXCL11) as depicted by the web interface. (b) Tabular information on proteolytic processing at position 25 and 84 by
different proteases along with evidence information and affected features. (c) Abstract of the publication describing the cleavage events depicted in b
as it is displayed along with other evidence information by the web interface.
D356 Nucleic AcidsResearch, 2012, Vol.40,Database issueto controlled vocabularies. Uploaded and submitted data
will be reviewed for completeness and data integrity by the
TopFIND curators before it is made available to the
public.
Evidence based ﬁltering. A key feature of TopFIND is the
opportunity to ﬁlter search results by several detailed
quantitative and qualitative evidence categories for each
entry, including directness, physiological relevance, conﬁ-
dence value and type, evidence code, tissue distribution,
experimental method, source database, source laboratory
and source publications as deﬁned above.
By default, all information linked to a query is dis-
played on the search result page. This can be customized
through several ﬁlter options accessible on the top right
side of the web interface or by adding speciﬁc parameters
to an API query call. After ﬁltering, only data that is
backed with evidence matching the chosen ﬁlter settings
is returned. This will affect the listed termini, cleavage sites
and substrates. Also the new network view will only
display connections matching the speciﬁed criteria, and
for proteases the displayed cleavage site preference will
be re-calculated. This ﬁlter system provides a powerful
tool for deeper analysis of the provided data.
Terminus centric data retrieval. In addition to the protein
centric approach described above, information on protein
termini can be searched for and retrieved in a terminus
centric approach. Queries return a list of matching protein
C-termini or N-termini including sequence excerpts, their
position in the protein sequence, modiﬁcations and a link
to the corresponding protein page and evidence informa-
tion. A ﬂexible interface enables a variety of searches by
amino acid sequence or sequence pattern (using a regular
expression syntax described in detail in the online help),
modiﬁcation, position, species, or speciﬁc proteins. The
results can be exported as comma separated spreadsheet
for further ofﬂine analysis and visualization.
USAGE AND DATA MINING
In the following paragraphs we illustrate how TopFIND
can be interrogated to extract new and useful information.
One prominent example of how minor differences in the
length and start of a protein chain can profoundly affect
protein function are chemokines (32). For example iden-
tiﬁcation of a N-terminus at position 25 of human C-X-C
motif chemokine 11 (CXL11, UniProtKB accession
O14625) can spark interest in the functional state of this
chemokine. TopFIND reveals that a number of cleavage
events cluster shortly after the start and before the end of
the annotated mature chemokine chain (Figure 3a). One
of those cleavage events matches the position of the
N-terminus under investigation. The detailed information
on this cleavage and similarly the other cleavage events
clustered at the N- and C-terminal ends of the chain lists
a number of different proteases that have been shown to
process CXL11 at these positions (Figure 3b). The
abstract of the related publication can be pulled up for
each of these, often providing important information on
the physiological role of the cleavage (Figure 3c). In this
example the abstract reveals that a N-terminus at position
25 represents a processed form that lost the agonistic
properties of the mature active form of CXL11. It also
indicates that for full functional characterization the
precise C-terminus of the chain has to be determined as
it directly affects glycosaminoglycan binding and antagon-
istic activity (33).
A query for murine a-enolase (UniProtKB accession
P17182) using the web interface displays the stored infor-
mation overlaid onto the protein sequence and predicted
protein domains. This includes a long list of cleavage sites
Figure 4. Browsing the protease web. (a) The protease web centered on vitamin K-dependent protein C as visualized in the TopFIND web interface.
(b) Enlarged section of the network depicted in a highlighting the strong interconnectivity with proteases (V shapes) cleaving (blue arrows) normal
proteins (circles) and other proteases themselves (circular arrow for THRB). The inhibitors involved are also shown (red bars).
Nucleic Acids Research, 2012,Vol.40, Database issue D357Figure 5. Protease sequence speciﬁcity with different ﬁlter settings. Heatmap and iceLogo representations of the sequence speciﬁcity of human
caspase 3 as displayed by the TopFIND web interface using different ﬁlter settings. (a) Unﬁltered, all cleavage events site sequences are taken into
account (n=410). (b) Filtered for the sequences reported in a single study by Park et al.( n=2). (c) Filtered by methodology selecting all sequences
tagged with the MEROPS method classiﬁer of ‘MU’ representing substrate identiﬁcation by mutation (n=5). (d) Filtered by sequences reported
using the method ‘PICS’ (41)( n=36).
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a few amino acids. However, many of the termini are
inferred from proteolytic processing, which may in part
represent degradative events that do not result in stable,
functional protein fragments. A user may therefore
question whether any termini have been directly
observed, and so can select for these by setting the ‘direct-
ness’ ﬁlter option to ‘direct’. This greatly reduces the
number of N- and C-termini to only those that have
been experimentally veriﬁed. Interestingly, several of
these N-termini are distributed across the whole polypep-
tide, indicating that several different stable protein chains
are generated by proteolytic processing. This corresponds
well with the general annotation derived from UniProtKB
and displayed in the annotation section describing
a-enolase as multifunctional enzyme involved in various
processes at locations as different as the cytoplasm and the
cell surface (34).
Similarly, the positional cross-correlation of mutations
or sequence variants in a protein of interest with observed
cleavage sites can indicate that the physiological effect
of these mutations might be triggered by modifying or
abolishing cleavage at a given site. Using TopFIND,
several somatic mutations in the tumor suppressor
protein p53 were found to coincide with a caspase-3
cleavage site, which is abolished by mutation. Hence,
lack of caspase cleavage at this site during apoptosis
potentially diminishes the cancer-protective functions of
p53 (17).
TopFIND is especially valuable for researchers inter-
ested in proteases and their inhibitors, as it provides a
unique tool to investigate the multiple interdependencies
between proteases, substrates and their inhibitors collect-
ively known as the protease web (35). For example, a
query for human vitamin-K dependent protein C
(protein C, UniProtKB accession P04070), a serine
protease that acts as a major anticoagulation factor (36),
shows a complicated network of interacting proteases, in-
hibitors and substrates (Figure 4a) that can be studied
more closely by zooming in (Figure 4b). The displayed
interactions show that protein C is a substrate of furin
and thrombin, which reﬂect limited processing during se-
cretion by furin and activation from its zymogen precursor
by thrombin. Hence, this identiﬁes coagulation factors V
and VIII as protein C substrates. The network view
further illustrates other proteases cleaving the same sub-
strates, proteases and inhibitors affecting upstream
located proteases such as thrombin, and other substrates
of proteases that interact with protein C. A simple click on
any of the displayed proteins opens the associated
TopFIND result page and thereby focuses the network
on this next level of interactions.
TopFIND can also be used to infer protease cleav-
age site preferences (17). The query result for human
caspase-3 (UniProtKB accession P42574) contains a
large number of substrate cleavage events that are also
summarized as an iceLogo. The logo clearly shows the
well known strong cleavage site preference for Asp at P1
(37) directly preceding the cleavage site, and an addition-
al preference for Asp at P4. TopFIND ﬁlter options
can be used to compare cleavage events reported in
different publications, derived from different resources
or obtained by different methods (Figure 5). This and
similar searches may be used to query the substrate
lists and displayed cleavage logos and to identify
potential biases introduced by chosen experimental
conditions.
CONCLUSION AND FUTURE DEVELOPMENTS
TopFIND provides a central repository and access point
for knowledge on protein termini, their modiﬁcations and
proteolytic processes in general. More importantly, by dis-
playing this positional correlated information TopFIND
assists researchers in intuitively creating new, experimen-
tally testable hypotheses for the role of proteins and
protein domains and their modiﬁcations, including pro-
teolytic processing, in health and disease.
In addition to regular updates of the knowledgebase
content we have identiﬁed three focus areas for the
future development of TopFIND. First, the ongoing
effort of integration with other existing or new resources
and analysis pipelines is core to provide even better access
to the stored data. Hence we will improve integration with
UniProt and MEROPS, not only on the user level but also
heavily on the level of data exchange. We also plan to
improve the import and visualization of the network
knowledge by Cytoscape.
Second, we regard the full integration of protein
isoforms as well as spatial-temporal and structural infor-
mation as the next important step forward. To this end we
are working on the integration of resources like functional
gene expression data (38), ProteinAtlas (39) and structural
mapping of termini and cleavage sites.
Third, TopFIND is fully supporting the Human
Proteome Project (HPP) (40). As part of this international
effort to map the complete human proteome, its modiﬁ-
cations and spatiotemporal variations in healthy subjects
and eventually across diseases and disease states,
TopFIND will act as central hub for all knowledge
generated by the terminome subprojects. Bidirectional
data exchange with participating research laboratories
and the central HPP knowledge hub neXtProt (http://
www.nextprot.org/) is already one important aspect of
this. More importantly however, TopFIND will integrate
the assembled knowledge to guide researchers in identiﬁ-
cation of proteins, tissues and disease states that need
further investigation to reach completeness.
We believe that the many unique features of TopFIND,
in particular the ability to gather seemingly disparate evi-
dences on events and modiﬁcations that can alter protein
termini or generate new termini, make TopFIND a
powerful new tool for assigning protein function. By
such data integration, information from terminomics
and other experiments can be converted into knowledge.
We hope that TopFIND will be a foundation for new
hypotheses and exciting new concepts on protein
function that spring from knowledge of the alterations
made at the end of the protein chain and not just the
end of a protein’s life.
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